DEFINITIVE CO-DEVELOPMENT & COMMERCIALIZATION AGREEMENT BETWEEN NABI BIOPHARMACEUTICALS AND KEDRION S.P.A.Co-Development & Commercialization Agreement • August 2nd, 2006 • Nabi Biopharmaceuticals • Biological products, (no disgnostic substances) • New York
This Agreement (including the Schedules hereto, the “Agreement”) is made this 19th day of June 2006 (the “Effective Date”) by and between Nabi Biopharmaceuticals (together with its Affiliates, “Nabi”), a Delaware corporation, with its principal office at 5800 Park of Commerce Blvd. N.W. Boca Raton, FL 33487 USA, and Kedrion S.p.A. (together with its Affiliates, “Kedrion”), a corporation organized under the laws of Italy, with its principal office at 55020 Castelvecchio Pascoli (Lucca) Italy, each on behalf of itself and its Affiliates (as defined below).
